Skip to main content
MedPathMedPath Home
Clinical Trials/DRKS00031915
DRKS00031915
Recruiting
Not Applicable

Continuous glucose monitoring in people with type 2 diabetes undergoing cardiac surgery - a cohort trial - CCS-1

Medizinische Universität Graz0 sites160 target enrollmentJune 1, 2023
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsE11Type 2 diabetes mellitus

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
E11
Sponsor
Medizinische Universität Graz
Enrollment
160
Status
Recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 1, 2023
End Date
TBD
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • •a) People with type 2 diabetes either on dietary control or on glucose lowering treatment including any oral glucose lowering drugs or GLP1\-receptor agonists
  • •b) Admitted to hospital for cardiac surgery (coronary artery bypass surgery or valve replacement)
  • •c) Age 50\-80 years (both inclusive)
  • •d) Written informed consent

Exclusion Criteria

  • •a) Type 1 diabetes
  • •b) Pre\-existing insulin treatment
  • •c) Insulin pump treatment
  • •d) Glucocorticoid treatment
  • •e) End stage renal disease
  • •f) Severe liver impairment
  • •g) Any mental condition rendering the patient incapable of giving informed consent
  • •h) Participation in another trial which might interfere with the procedures of this trial

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
Continuous Glucose Monitoring System in patients with Cystic FibrosisCystic fibrosis and diabetes1003868610018424
NL-OMON31821HagaZiekenhuis18
Completed
Not Applicable
Continuous glucose monitoring during diets that differ in glycemic loadMetabolismeGlucose metabolismrisk factor for type 2 diabetes mellitus
NL-OMON43100nilever23
Completed
Not Applicable
Continuous glucose monitoring (CGM) in advanced neurodegenerative diseasesneurodegenerative diseases0
JPRN-jRCT1090220372ational Health Organization Hyogo-Chuo National Hospital10
Not yet recruiting
Phase 4
Role of continuous glucose monitoring device on diabetes patientHealth Condition 1: E119- Type 2 diabetes mellitus without complications
CTRI/2024/02/062647Dr.Priyamadhabha Behera
Completed
Not Applicable
Professional Continuous Glucose Monitoring versus Self-Monitoring of Blood Glucose in children with Type 1 Diabetes MellitusHealth Condition 1: null- Type 1 Diabetes Mellitus
CTRI/2017/02/007937PGIMER Chandigarh70